Ipilimumab/nivolumabEpidermolysis bullosa aquisita, autoimmune hepatitis and sinusitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1916卷 / 1期

关键词：

D O I：

10.1007/s40278-022-19698-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：239 / 239

相关论文

共 50 条

[1] Ipilimumab/nivolumabAutoimmune hepatitis and autoimmune thyroiditis: case report
[J]. Reactions Weekly, 2017, 1665 (1) : 162 - 162
[2] Ipilimumab/nivolumabGrade 3 autoimmune hepatitis: case report
[J]. Reactions Weekly, 2022, 1929 (1) : 359 - 359
[3] Ipilimumab/nivolumabThrombocytopenia, neutropenia and autoimmune hepatitis: case report
[J]. Reactions Weekly, 2018, 1725 (1) : 184 - 184
[4] Ipilimumab/pembrolizumabDiarrhoea, autoimmune hepatitis and eosinophilic fasciitis: case report
[J]. Reactions Weekly, 2019, 1778 (1) : 260 - 260
[5] Ipilimumab/nivolumabAutoimmune colitis, acute interstitial nephritis and autoimmune hepatitis: case report
[J]. Reactions Weekly, 2021, 1882 (1) : 253 - 253
[6] Ipilimumab/nivolumabEnteritis and hepatitis: case report
[J]. Reactions Weekly, 2018, 1696 (1) : 214 - 214
[7] Ipilimumab/nivolumabAutoimmune hepatitis: case report
[J]. Reactions Weekly, 2022, 1910 (1) : 266 - 266
[8] Ipilimumab/nivolumabAutoimmune hepatitis: case report
[J]. Reactions Weekly, 2022, 1889 (1) : 182 - 182
[9] Ipilimumab/nivolumabAutoimmune hepatitis: case report
[J]. Reactions Weekly, 2018, 1733 (1) : 207 - 207
[10] Ipilimumab/nivolumabAutoimmune hepatitis: case report
[J]. Reactions Weekly, 2019, 1752 (1) : 218 - 218

← 1 2 3 4 5 →